Publications by authors named "Subir Roy"

Claim this Profile
S
Switching of ferroelectric liquid crystal doped with cetyltrimethylammonium bromide-assisted CdS nanostructures.
Kaushik Pal, Uday Narayan Maiti, Tapas Pal Majumder, Subhas Chandra Debnath, Sharmistha Ghosh, Subir Kumar Roy

Nanotechnology· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Voltage induced anomalous conductance switching behaviour in nematic liquid crystal-multiwalled carbon nanotube composite.
Prasenjit Nayek, Subir Kumar Roy, Roman Dabrowski

J Nanosci Nanotechnol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of age and obesity on serum estradiol, estrone, and sex hormone binding globulin concentrations following oral estrogen administration in postmenopausal women.
Roksana Karim, Wendy J Mack, Howard N Hodis, Subir Roy, Frank Z Stanczyk

J Clin Endocrinol Metab· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term oral dehydroepiandrosterone treatment in postmenopausal women.
Frank Z Stanczyk, Cristin C Slater, Diana E Ramos, Colleen Azen, Ganesh Cherala, Subir Roy

Menopause· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hierarchical assembly of carbon nanotubes-liquid crystal nanocomposite.
Sudarshan Kundu, Sudip K Batabyal, Prasenjit Nayek, Subir K Roy

J Nanosci Nanotechnol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of liquid crystal environment on the spectroscopic and photophysical properties of well-known reacting systems 2,3-dimethylindole (DMI) and 9-cyanoanthracene (9CNA).
Paulami Mandal, Sudarshan Kundu, Tapas Misra, Subir Kumar Roy, Tapan Ganguly

J Phys Chem A· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Percutaneous administration of progesterone: blood levels and endometrial protection.
Frank Z Stanczyk, Richard J Paulson, Subir Roy

Menopause· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam.
Joseph Solomkin, Hedy Teppler, Donald R Graham, Richard M Gesser, Anne R Meibohm, Subir Roy

J Antimicrob Chemother· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving appropriate use of antifungal medications: the role of an over-the-counter vaginal pH self-test device.
Subir Roy, James C Caillouette, Joel S Faden, Tapon Roy, Diana E Ramos

Infect Dis Obstet Gynecol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: a prospective, multicenter, randomized, double-blind study.
Subir Roy, Iliana Higareda, Edith Angel-Muller, Mahmoud Ismail, Caren Hague

Infect Dis Obstet Gynecol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacologic deficiency in the Women's Health Initiative Study.
Frank Z Stanczyk, Sukanya Chaikittisilpa, Subir Roy

J Reprod Med· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: results from the estrogen in the prevention of atherosclerosis trial.
Wendy J Mack, Afshan B Hameed, Min Xiang, Subir Roy, Cristin C Slater

Atherosclerosis· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Growth effects of raloxifene, estradiol, medroxy-progesterone acetate, and progesterone on human endometrial adenocarcinoma cells.
Robert Boostanfar, Charles A Amezcua, David E Tourgeman, Subir Roy, Juan C Felix

Fertil Steril· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis